Navigation Links
Talyst Unveils InSite for Long-Term Care
Date:11/19/2008

BELLEVUE, Wash., Nov. 19 /PRNewswire/ -- Talyst, a leader in automated medication management, today unveiled InSite(TM) for Long-Term Care. InSite is the first remote dispensing system designed exclusively for long-term care facilities and the patients in their care.

The company made the announcement at the annual meeting of the American Society of Consultant Pharmacists, underway this week in New Orleans. The first installations of the InSite system are operating in Texas, and each InSite unit will deliver an estimated 1.5 million oral medication doses per year. The automated system enables on-site, on-demand medication dispensing for an entire facility. With InSite for Long-Term Care, medication waste is virtually eliminated. The hardware and software solution cuts nursing medication prep time in half and allows late admissions and quick first doses.

The benefits of remote dispensing

InSite allows an institutional pharmacy to place a secure, freestanding remote dispensing system at each long-term care facility they support. "Talyst is continuing to build market leadership through innovation," explains Carla Corkern, chief executive officer, "and InSite is our response to a clear need in the long-term care industry." She added, "With a national nursing shortage, rising medication budgets and the need for improved medication safety, InSite for Long-Term Care can help both facilities and pharmacies save time and reduce waste while creating a safer medication process."

The InSite Remote Dispensing System improves the partnership between pharmacies and the facilities they support. Medication orders are submitted to the institutional pharmacy for clinical review, and approved orders are available immediately from the remote dispensing unit at the facility. Rather than filling medication orders for 30 days at a time, InSite enables medications to be sorted by patient and packaged at the facility. The clearly labeled multi-dose and single-dose packages are prepared on demand with patient name, med pass time and a detailed listing of each medication. Medication usage is monitored at the institutional pharmacy to provide complete inventory control and medication canisters are safely filled and secured for transportation to the facility as needed.

"In early installations of InSite, nursing medication prep time was reduced by about 75%, and the institutional pharmacy was able to reduce the number of trips made to the facility each week, and Medicare Part A waste was nearly eliminated," Corkern noted. "In addition, medications for new patients, or changes to an existing patient's medications, are available to nursing staff virtually immediately."

Corkern concludes, "The bottom line is that InSite reduces costs, saves time and keeps the patients safer."

About Talyst

Talyst enables the safer pharmacy. The company provides automated systems to hospitals, long-term care facilities and correctional systems, to improve accuracy and patient safety, while reducing costs and increasing productivity. Talyst equipment and software are used to package, barcode, store and track medication inventories. The company has more than 300 hospital and integrated healthcare system customers.

For more information, see http://www.talyst.com/LTC or call 877-4-Talyst (877-482-5978).

For the last two years, Talyst has ranked in the "Inc. 500" national list of fastest-growing private companies. Last month, the company was ranked number two on the Deloitte "Fast 50" Technology Companies in Washington state. Talyst was also honored by Fast Company magazine's "Fast 50 Reader Favorites" list, honoring innovative, progressive enterprises.

Talyst and InSite are trademarks of Talyst Inc. Other trade names are the property of their respective owners.


'/>"/>
SOURCE Talyst
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Catalyst Biosciences Appoints Dr. Todd Lorenz Chief Medical Officer
2. Catalyst mystery unlocked
3. CATalyst Council Forms to Address Feline Health Care
4. Congress Approves ePrescribing Initiative in Medicare Reform Bill: Critical Catalyst in Driving a New Generation of Prescribing
5. Catalyst Pharmaceutical Partners, Inc. Set to Join Russell Microcap(R) Index
6. Case in Point: Patient Control of Data Critical Catalyst for Online Health Care Revolution
7. Catalyst Pharmaceutical Partners, Inc. Names Director - Corporate Clinical Compliance
8. Cardiva Medical, Inc. to Present Highlights of the Boomerang Catalyst(TM) II System at the Investment in Innovation (In3) West Conference on February 29, 2008 in Las Vegas, NV
9. CATalyst Summit Declared a Success: Its All About the Cat!
10. Catalyst Pharmaceutical Partners Announces Positive Phase II Trial Results for Vigabatrin in the Treatment of Cocaine Addiction
11. Catalyst Pharmaceutical Partners Reports Third Quarter 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/20/2017)... (PRWEB) , ... September 20, 2017 , ... “Finn Mouseson”: ... take precedence in an average life. This mouse sets out on a journey that ... heart. “Finn Mouseson” is the creation of newly published author and illustrator, Melody Gersonde-Mickelson, ...
(Date:9/20/2017)... ... ... “The Financial Favor of God; Second Edition”: a personal and exquisite recipe ... creation of published author, Brooks Rathell. , “We typically hear about the favor of ... financial favor of God. Not only does it exist, but it is meant for ...
(Date:9/19/2017)... ... September 19, 2017 , ... DeSola Group, ... marketing leader, Denise Flannery, to its strategic advisory and client development team. ... will work with clients across different industries to develop and implement market-justified strategies, ...
(Date:9/19/2017)... ... 2017 , ... The Lymphoma Research Foundation (LRF) – the ... the lymphoma community through a comprehensive series of education programs, outreach initiatives and ... Swirl: A Wine Tasting Event series on Thursday, October 26, 2017. Hosted at ...
(Date:9/19/2017)... MD (PRWEB) , ... September 19, 2017 , ... ... the Society of Professional Benefit Administrators (SPBA) hosted “Expanding Your Success” ... for SPBA Members as it focused on best practices for third party administrators ...
Breaking Medicine News(10 mins):
(Date:9/12/2017)... 12, 2017  ValGenesis Inc., the global leader ... pleased to announce the appointment of Dr. ... Board of Directors and Chairman of Advisory Board ... science companies to manage their entire validation lifecycle ... in this process. Furthermore, ValGenesis VLMS enables rigorous ...
(Date:9/9/2017)... Sept. 9, 2017  Eli Lilly and Company (NYSE: ... secondary endpoint data for lasmiditan, an investigational, oral, first-in-class ... statistically significant improvements compared to placebo in the Phase ... at the 18th Congress of the International Headache Society ... "The data presented today demonstrate lasmiditan,s potential to reduce ...
(Date:9/7/2017)... 7, 2017 Caris Life Sciences, a ... the promise of precision medicine, today announced results ... of its molecular profiling approach in guiding therapeutic ... profiling plus (CGP+) with Caris Molecular Intelligence ® ... a molecular level, leading to more therapeutic options ...
Breaking Medicine Technology: